Royalty Pharma Plc (RPRX) reported its Q4 2024 earnings today, revealing earnings per share (EPS) of $0.3531, falling short of the forecasted $0.9849. The company also reported revenue of $594 million ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25 If approved, FILS ...

Aclaris' stock has dropped nearly 70% since September 2023, reflecting its history of failures and dissipations. Explore more ...

They line up by the hundreds to meet recruiters at schools in provincial towns and convention halls in large cities, some ...

Opera Theatre of Saint Louis has a rich history in world premiers, often commissioning new works from  significant composers ...

A federal judge dismissed a lawsuit against Baton Rouge officials over the 2022 police chase crash that killed Brusly High ...

The conference then took an inspirational turn with the appearance of tennis legend Andre Agassi. Known for his remarkable 20 ...

NPR's Ayesha Rascoe talks with director Dawn Porter. Her new documentary, "Luther: Never Too Much," tracks the life and music ...

Miguel Espinoza, a local accountant and community leader, is running for Abilene City Council Place 5, challenging longtime ...

Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...

ASUS phones have always piqued my interest partly because I'm a fan of ASUS products, but this would be my first time testing ...

That may be true, but once there is no excess liquidity sloshing around the system, liquidity drained by QT will have to come ...